Logo

Rheonix: Stephen Thomas

Jul 21, 2022

Molecular diagnostic testing company Rheonix has appointed Stephen Thomas as chief medical officer and a member of the firm's board. He is a professor of medicine and microbiology and immunology at SUNY Upstate Medical University and directs the Institute for Global Health and Translational Science. He is also interim chair of the department of microbiology and immunology. Additionally, Thomas is the global coordinating principal investigator for Pfizer's Phase 1/2/3 COVID vaccine trial.

Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.